CPT\/HCPCS
\nCode Laboratory Code Long Descriptor Code Category
\nCOVID-19 Related Codes
\nU0001 CDC 2019-nCoV Real-Time RT-PCR Diagnostic Panel COVID-19
\nU0002
\n2019-nCoV Coronavirus, SARS-CoV-2\/2019-nCoV (COVID-19), any technique, multiple types or
\nsubtypes (includes all targets), non-CDC)
\nCOVID-19
\nU0003
\nInfectious agent detection by nucleic acid (DNA or RNA); severe acute respiratory syndrome
\ncoronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]), 2 amplified probe technique, making
\nuse of high throughput technologies as described by CMS-2020-01-R
\nCOVID-19
\nU0004
\n2019-nCoV Coronavirus, SARS-CoV-2\/2019-nCoV (COVID-19), any technique, multiple types or
\nsubtypes (includes all targets), non-CDC, making use of high throughput technologies as described by
\nCMS-2020-01-R
\nCOVID-19
\n87635
\nInfectious agent detection by nucleic acid (DNA or RNA); severe acute respiratory syndrome
\ncoronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]), amplified probe technique
\nCOVID-19
\n86769
\nAntibody; severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease
\n[COVID-19])
\nCOVID-19
\n86328
\nImmunoassay for infectious agent antibody(ies), qualitative or semiquantitative, single step method
\n(eg, reagent strip); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus
\ndisease [COVID-19])
\nCOVID-19
\nInfluenza\/RSV Related Codes
\n87275 Infectious agent antigen detection by immunofluorescent technique; influenza B virus Influenza\/RSV
\n87276 Infectious agent antigen detection by immunofluorescent technique; influenza A virus Influenza\/RSV
\n87279 Infectious agent antigen detection by immunofluorescent technique; Parainfluenza virus, each type Influenza\/RSV
\n1
\n04\/30\/2020<\/p>\n\n\n\n
CPT\/HCPCS
\nCode Laboratory Code Long Descriptor Code Category
\nCOVID-19 Related Codes
\n87400
\nInfectious agent antigen detection by immunoassay technique, (eg, enzyme immunoassay [EIA],
\nenzyme-linked immunosorbent assay [ELISA], immunochemiluminometric assay [IMCA]) qualitative
\nor semiquantitative, multiple-step method; Influenza, A or B, each
\nInfluenza\/RSV
\n87501
\nInfectious agent detection by nucleic acid (DNA or RNA); influenza virus, includes reverse
\ntranscription, when performed, and amplified probe technique, each type or subtype
\nInfluenza\/RSV
\n87502
\nInfectious agent detection by nucleic acid (DNA or RNA); influenza virus, for multiple types or subtypes, includes multiplex reverse transcription, when performed, and multiplex amplified probe
\ntechnique, first 2 types or sub-types
\nInfluenza\/RSV
\n87503
\nInfectious agent detection by nucleic acid (DNA or RNA); influenza virus, for multiple types or subtypes, includes multiplex reverse transcription, when performed, and multiplex amplified probe
\ntechnique, each additional influenza virus type or sub-type beyond 2 (List separately in addition to
\ncode for primary procedure)
\nInfluenza\/RSV
\n87631
\nInfectious agent detection by nucleic acid (DNA or RNA); respiratory virus (eg, adenovirus, influenza
\nvirus, coronavirus, metapneumovirus, parainfluenza virus, respiratory syncytial virus, rhinovirus),
\nincludes multiplex reverse transcription, when performed, and multiplex amplified probe technique,
\nmultiple types or subtypes, 3-5 targets
\nInfluenza\/RSV
\n87632
\nInfectious agent detection by nucleic acid (DNA or RNA); respiratory virus (eg, adenovirus, influenza
\nvirus, coronavirus, metapneumovirus, parainfluenza virus, respiratory syncytial virus, rhinovirus),
\nincludes multiplex reverse transcription, when performed, and multiplex amplified probe technique,
\nmultiple types or subtypes, 6-11 targets
\nInfluenza\/RSV
\n87633
\nInfectious agent detection by nucleic acid (DNA or RNA); respiratory virus (eg, adenovirus, influenza
\nvirus, coronavirus, metapneumovirus, parainfluenza virus, respiratory syncytial virus, rhinovirus),
\nincludes multiplex reverse transcription, when performed, and multiplex amplified probe technique,
\nmultiple types or subtypes, 12-25 targets
\nInfluenza\/RSV
\n87804 Infectious agent antigen detection by immunoassay with direct optical observation; Influenza Influenza\/RSV
\n87280 Infectious agent antigen detection by immunofluorescent technique; respiratory syncytial virus Influenza\/RSV
\n04\/30\/2020 2<\/p>\n\n\n\n
CPT\/HCPCS
Code Laboratory Code Long Descriptor Code Category
COVID-19 Related Codes
87420
Infectious agent antigen detection by immunoassay technique, (eg, enzyme immunoassay [EIA],
enzyme-linked immunosorbent assay [ELISA], immunochemiluminometric assay [IMCA]) qualitative
or semiquantitative, multiple-step method; respiratory syncytial virus
Influenza\/RSV
87634
Infectious agent detection by nucleic acid (DNA or RNA); respiratory syncytial virus, amplified probe
technique
Influenza\/RSV
87807
Infectious agent antigen detection by immunoassay with direct optical observation; respiratory
syncytial virus
Influenza\/RSV Source: www.cms.gov <\/p>\n","protected":false},"excerpt":{"rendered":"
CPT\/HCPCS Code Laboratory Code Long Descriptor Code Category COVID-19 Related Codes U0001 CDC 2019-nCoV Real-Time RT-PCR Diagnostic Panel COVID-19 U0002 2019-nCoV Coronavirus, SARS-CoV-2\/2019-nCoV (COVID-19), any technique, multiple types or subtypes (includes all targets), non-CDC) COVID-19 U0003 Infectious agent detection by nucleic acid (DNA or RNA); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Coronavirus disease [COVID-19]), […]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-1188","post","type-post","status-publish","format-standard","hentry"],"_links":{"self":[{"href":"https:\/\/ircmhealth.com\/new\/wp-json\/wp\/v2\/posts\/1188","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ircmhealth.com\/new\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ircmhealth.com\/new\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ircmhealth.com\/new\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/ircmhealth.com\/new\/wp-json\/wp\/v2\/comments?post=1188"}],"version-history":[{"count":2,"href":"https:\/\/ircmhealth.com\/new\/wp-json\/wp\/v2\/posts\/1188\/revisions"}],"predecessor-version":[{"id":1190,"href":"https:\/\/ircmhealth.com\/new\/wp-json\/wp\/v2\/posts\/1188\/revisions\/1190"}],"wp:attachment":[{"href":"https:\/\/ircmhealth.com\/new\/wp-json\/wp\/v2\/media?parent=1188"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ircmhealth.com\/new\/wp-json\/wp\/v2\/categories?post=1188"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ircmhealth.com\/new\/wp-json\/wp\/v2\/tags?post=1188"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}